| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $6.02B | +2.6% |
| Gross profit | $3.81B | — |
| Operating income | $0.94B | — |
| Net income | $0.74B | +13.9% |
| Gross margin | 63.3% | Net margin 12.4% |
| Revenue Q/Q | -16.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| Traumaand Extremities | $1.03B | 17.2% |
| Instruments | $0.92B | 15.3% |
| Medical | $0.90B | 15.0% |
| Endoscopy | $0.87B | 14.4% |
| Knees | $0.67B | 11.1% |
| Ortho Tech | $0.65B | 10.7% |
| Neurovascular | $0.52B | 8.6% |
| Hips | $0.46B | 7.6% |
| Spinal Implants | $0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $2.21B | 36.7% |
| R&D | $0.41B | 6.9% |
| SG&A | $2.28B | 37.9% |
| Tax & other | $0.19B | 3.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
SMCI ・ SYF ・ SNPS ・ SYY ・ TMUS ・ TROW ・ TTWO ・ TPR ・ TRGP ・ TGT ・ TEL ・ TDY
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies